Literature DB >> 17201528

Early cognitive deficits in Swedish gene carriers of Huntington's disease.

Tarja-Brita Robins Wahlin1, Anders Lundin, Keith Dear.   

Abstract

The primary focus of this study was to examine whether there is early neuropsychological impairment in presymptomatic Huntington's disease (HD). A broad neuropsychological assessment battery was administered to 24 asymptomatic gene carriers (HD+) and 31 noncarriers (HD-). The gene carriers revealed inferior cognitive functioning as compared with the noncarriers in memory and executive functions. When the gene carriers were assigned to 2 groups based on predicted years to onset (with 15 and over being HD+ late and under 15 being HD+ near), the HD+ near group performed significantly worse than the HD+ late group in all domains but ability to shift conceptually and visuospatial memory. Results suggest that early cognitive deficits are detectable prior to motor symptoms, first in memory functions and then in executive functions and perceptual motor speed. (c) 2007 APA, all rights reserved.

Entities:  

Mesh:

Year:  2007        PMID: 17201528     DOI: 10.1037/0894-4105.21.1.31

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  16 in total

1.  Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Authors:  Aaron C Rising; Jia Xu; Aaron Carlson; Vincent V Napoli; Eileen M Denovan-Wright; Ronald J Mandel
Journal:  Exp Neurol       Date:  2010-12-28       Impact factor: 5.330

2.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

Review 3.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

4.  Neurocognitive signs in prodromal Huntington disease.

Authors:  Julie C Stout; Jane S Paulsen; Sarah Queller; Andrea C Solomon; Kathryn B Whitlock; J Colin Campbell; Noelle Carlozzi; Kevin Duff; Leigh J Beglinger; Douglas R Langbehn; Shannon A Johnson; Kevin M Biglan; Elizabeth H Aylward
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

5.  Suicidal behavior in prodromal Huntington disease.

Authors:  Jess G Fiedorowicz; James A Mills; Adam Ruggle; Douglas Langbehn; Jane S Paulsen
Journal:  Neurodegener Dis       Date:  2011-06-09       Impact factor: 2.977

6.  Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease.

Authors:  Aldrin E Molero; Solen Gokhan; Sara Gonzalez; Jessica L Feig; Lucien C Alexandre; Mark F Mehler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

7.  Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease.

Authors:  Andrea C Solomon; Julie C Stout; Marjorie Weaver; Sarah Queller; Allison Tomusk; Kathryn Burr Whitlock; Siu L Hui; Jeanine Marshall; Jacqueline Gray Jackson; Eric R Siemers; Xabier Beristain; Joanne Wojcieszek; Tatiana Foroud
Journal:  Mov Disord       Date:  2008-10-15       Impact factor: 10.338

8.  Towards humane end points: behavioural changes precede clinical signs of disease in a Huntington's disease model.

Authors:  Kate Littin; Abraham Acevedo; William Browne; Joanne Edgar; Mike Mendl; Diane Owen; Chris Sherwin; Hanno Würbel; Christine Nicol
Journal:  Proc Biol Sci       Date:  2008-08-22       Impact factor: 5.349

9.  Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease.

Authors:  M F Ghilardi; G Silvestri; A Feigin; P Mattis; D Zgaljardic; C Moisello; D Crupi; L Marinelli; A Dirocco; D Eidelberg
Journal:  Parkinsonism Relat Disord       Date:  2008-03-03       Impact factor: 4.891

10.  The relationship between cortisol and verbal memory in the early stages of Huntington's disease.

Authors:  Christopher A Shirbin; Phyllis Chua; Andrew Churchyard; Anthony J Hannan; Georgia Lowndes; Julie C Stout
Journal:  J Neurol       Date:  2012-11-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.